IV CR845: Phase Ib data

Top-line data from a double-blind, placebo-controlled Phase Ib trial in 24 hemodialysis patients showed that 0.5-2.5 µg/kg doses of IV CR845 as a bolus dose given after each dialysis session up to 3 t...